Syros Pharmaceuticals, Inc. Skyrocketed
Tue, Mar 11, 2025 at 07:57 PM
Syros Pharmaceuticals, Inc. (SYRS:NASDAQ) rocketted at $0.14, representing a gain of 48.5%. On Tue, Mar 11, 2025, SYRS:NASDAQ hit a New 2-Week Intraday High of $0.3. The stock got featured on our News Catalysts scanner on Tue, Mar 04, 2025 at 02:53 AM in the 'MISCELLANEOUS' category. From Tue, Feb 25, 2025, the stock recorded 20.00% Up Days and 27.27% Green Days
The stock spiked on Tue, Mar 11, 2025 at $0.3 with a volume of 691M+.
About Syros Pharmaceuticals, Inc. (SYRS:NASDAQ)
Syros Pharmaceuticals Inc is a biopharmaceutical company pioneering an understanding of the region of the genome controlling the activation and repression of genes.
Top 10 Gainers:
- Raytech Holding Limited (RAY:NASDAQ), 94.25%
- 2seventy bio Inc. (TSVT:NASDAQ), 76.79%
- Hesai Group (HSAI:NASDAQ), 50.41%
- Syros Pharmaceuticals, Inc. (SYRS:NASDAQ), 48.47%
- Springview Holdings Ltd (SPHL:NASDAQ), 47.06%
- Cryoport, Inc. (CYRX:NASDAQ), 41.49%
- Myomo, Inc. (MYO:NYSEMKT), 40.77%
- Ramaco Resources, Inc. (METC:NASDAQ), 38.33%
- Maiden Holdings, Ltd. (MHLD:NASDAQ), 33.2%
- Dogwood Therapeutics Inc. (DWTX:NASDAQ), 31.87%